Remedy Pharmaceuticals
CompanyUnited States
Remedy Pharmaceuticals develops one asset, in phase 3 (BIIB093 in acute stroke). Mostly small molecule; based in the United States.
- 1
- Asset
- Furthest stage
- Phase 3
- Raised
- $15.4M
- 5
- Trials
- 0
- Signals
Pipeline
1Phase 3, Small molecule, acute stroke, brain edema
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Evidence behind the mechanisms1
- Trials5
- Funding rounds and grants5
- Similar companies6